Oct 31 (Reuters) - A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals (VRTX.O), opens new tab and CRISPR Therapeutics (CRSP.BN), opens new tab could assess ...
The Food and Drug Administration is convening a meeting of outside experts on Tuesday to review exa-cel, a CRISPR-based treatment for sickle cell disease made by Vertex Pharmaceuticals and CRISPR ...
Oct 21 (Reuters) - A U.S. Food and Drug Administration advisory panel on Tuesday voted 13-2 to recommend expanding approval of Vertex Pharmaceuticals Inc's cystic fibrosis drug Kalydeco to include a ...
A group of independent experts to the US FDA for the most part embraced a first of its kind gene editing therapy developed by CRISPR Therapeutics (NASDAQ:CRSP) and Vertex Pharma (NASDAQ:VRTX) for ...
After reaching FDA first, CRISPR-Vertex's gene editing therapy will get 'benign' review by committee
A historic moment in pharmaceuticals will happen next week: an FDA advisory committee is set to review the first-ever CRISPR gene editing-based therapy, Vertex Pharmaceuticals and CRISPR Therapeutics’ ...
Trina Solar says it has launched mass production of 430 W to 455 W full-black PV modules. The Vertex S+ panels have efficiencies of up to 22.8% and weigh 21 kg, with a 1.6 mm x 1.6 mm dual-glass ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) - A panel of advisers to the U.S. health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results